APRIGLIM M1 TAB

Description

APRIGLIM M1 Tablet is a combination therapy used in the management of type 2 diabetes. The tablet contains Glimepiride 1 mg, a sulfonylurea that stimulates the pancreas to release more insulin, and Metformin, a biguanide that helps reduce glucose production in the liver and improves the body’s sensitivity to insulin. This dual-action approach helps improve blood sugar control in patients who are unable to manage their diabetes with lifestyle changes alone.

APRIGLIM M1 is typically taken once daily with food to help minimize gastrointestinal side effects and reduce the risk of low blood sugar (hypoglycemia). Regular blood sugar monitoring is recommended to ensure optimal control and adjust the dosage as needed.

Key Benefits:

• Glimepiride stimulates insulin secretion, while Metformin improves insulin sensitivity

• Effective in controlling blood sugar levels in type 2 diabetes

• Typically taken once daily with food

• Helps reduce the risk of complications from uncontrolled blood sugar

• Should be used as part of a complete diabetes management plan, including diet and exercise